¼¼°èÀÇ POC(Point of Care) ÀÀ°í °Ë»ç ½ÃÀå º¸°í¼­(2025³â)
Point-of-Care (POC) Coagulation Testing Global Market Report 2025
»óǰÄÚµå : 1694792
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,426,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,288,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 12,150,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

½ÉÇ÷°ü Áúȯ(CVD)ÀÇ ¹ßº´·ü Áõ°¡·Î ÀÎÇØ ÇöÀå ÀÀ°í °Ë»ç ½ÃÀåÀÌ ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, CVD¿¡´Â °ü»óµ¿¸Æ Áúȯ, ³úÇ÷°ü Áúȯ µî ½ÉÀå°ú Ç÷°ü¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ´Ù¾çÇÑ ÁúȯÀÌ Æ÷ÇԵ˴ϴÙ. Àû½Ã¿¡ °³ÀÔÀ» °¡´ÉÇÏ°Ô Çϰí, ƯÈ÷ ½ÉÀå ¼ö¼ú ÈÄ ÃâÇ÷¼º ÇÕº´Áõ À§ÇèÀ» °¨¼Ò½ÃÅ´À¸·Î½á CVD Ä¡·á¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 5¿ù ¹Ì±¹ Áúº´¿¹¹æÅëÁ¦¼¾ÅÍ´Â 2021³â ¹Ì±¹¿¡¼­ ½ÉÀ庴ÀÌ ¾à 695,000¸íÀÇ ¸ñ¼ûÀ» ¾Ñ¾Æ°¥ °ÍÀ̸ç, »ç¸ÁÀÚ 5¸í Áß 1¸íÀÌ ½ÉÀ庴À¸·Î »ç¸ÁÇÒ °ÍÀ̶ó°í º¸°íÇß½À´Ï´Ù. °¡Àå ¸¹Àº °ü»óµ¿¸Æ¼º ½ÉÀåÁúȯÀº 2021³â¿¡ 375,476¸íÀÌ »ç¸ÁÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡´Â POC ÀÀ°í °Ë»ç ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇÏ´Â Áß¿äÇÑ ¿ä¼ÒÀÔ´Ï´Ù.

ÇöÀåÁø´Ü(POC) ÀÀ°í °Ë»ç ½ÃÀåÀÇ ÁÖ¿ä ¾÷üµéÀº °æÀï·ÂÀ» °­È­Çϱâ À§ÇØ Àü·«Àû Á¦ÈÞ¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¦ÈÞ¿¡´Â µÎ °³ ÀÌ»óÀÇ ´ç»çÀÚ°¡ ƯÁ¤ »óÈ£ ÀÌÀÍÀÌ µÇ´Â ¸ñÇ¥¸¦ ´Þ¼ºÇϱâ À§ÇØ Çù·ÂÇÏ´Â °ø½ÄÀûÀÎ °è¾àÀÌ Æ÷ÇԵ˴ϴÙ. ¿¹¸¦ µé¾î, 2021³â 10¿ù Æ®¸®ºñÆ®·Ð ÇコÄɾî´Â Diagon Ltd. ¹× Vanguard Diagnostics¿Í Á¦ÈÞÇÏ¿© ÀÀ°í ºÐ¼®±â Á¦Ç°À» Ãâ½ÃÇß½À´Ï´Ù. ÀÌ ºÐ¼®±â´Â Á¤È®Çϰí È¿À²ÀûÀÎ ÀÀ°í °Ë»ç¸¦ Á¦°øÇϸç, À̹ø Á¦È޴ ȯÀÚ Áø´Ü ¹× °ü¸®¸¦ °­È­ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. ´Ù¾çÇÑ ÀÇ·á ȯ°æ¿¡ ÀûÇÕÇϵµ·Ï ¼³°èµÇ¾î ÀÀ°í °Ë»ç¸¦ º¸´Ù ½±°Ô ÀÌ¿ëÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù.

2023³â 12¿ù, ½ºÀ§½º Á¦¾àȸ»ç ·Î½´´Â ·ç¹Ì¶óµ¦½º¸¦ 3¾ï 5,000¸¸ ´Þ·¯¿¡ ÀμöÇß½À´Ï´Ù. À̹ø Àμö¸¦ ÅëÇØ ·Î½´ÀÇ Áø´Ü¾à Æ÷Æ®Æú¸®¿À°¡ °­È­µÇ°í, ȯÀÚ ¿©Á¤ Àü¹ÝÀ» ¾Æ¿ì¸£´Â Ä¡·á ½ÃÁ¡ ¼Ö·ç¼ÇÀ» ÅëÇØ º¸´Ù ȯÀÚ Áß½ÉÀûÀÎ ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇÒ ¼ö ÀÖ°Ô µÆ½À´Ï´Ù. ¿µ±¹¿¡ º»»ç¸¦ µÐ ·ç¹Ì¶óµ¦½º´Â ÇöÀå ÀÀ°í °Ë»ç Àü¹® ±â¾÷ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, Äڷγª, ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Point-of-care (POC) coagulation testing is a diagnostic method that evaluates blood clotting function at or near the patient's location, rather than in a centralized lab. It provides rapid results, typically within minutes, enabling healthcare professionals to make timely treatment decisions and optimize anticoagulation therapy.

The main technologies used in POC coagulation testing are optical, mechanical, and electrochemical. Optical technology utilizes light for various applications, including data transfer, imaging, and sensing. These tests are distributed through channels such as direct tenders and retail to end-users such as hospitals, clinics, and home care settings.

The point-of-care (POC) coagulation testing market research report is one of a series of new reports from The Business Research Company that provides point-of-care (POC) coagulation testing market statistics, including point-of-care (POC) coagulation testing industry global market size, regional shares, competitors with a point-of-care (POC) coagulation testing market share, detailed point-of-care (POC) coagulation testing market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care (POC) coagulation testing industry. This point-of-care (POC) coagulation testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The point-of-care (POC) coagulation testing market size has grown strongly in recent years. It will grow from $1.18 billion in 2024 to $1.25 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to rise in patient demand, growing trend of point-of-care testing, high reliability of coagulation status on pt test, automation and integration with electronic health records (EHRs), rising incidence of cardiovascular diseases and blood disorders.

The point-of-care (POC) coagulation testing market size is expected to see steady growth in the next few years. It will grow to $1.48 billion in 2029 at a compound annual growth rate (CAGR) of 4.2%. The growth in the forecast period can be attributed to expanding applications in healthcare, rising demand in homecare settings, increased prevalence of chronic blood disorders, patient demand for rapid and accurate testing, rise in point-of-care testing. Major trends in the forecast period include technological advancements, high demand in developed countries, expanding applications in healthcare, COVID-19 impact, multiplexing POC diagnostics.

The point-of-care (POC) coagulation testing market is expected to grow due to the increasing incidence of cardiovascular diseases (CVDs). CVDs encompass a range of disorders affecting the heart and blood vessels, such as coronary heart disease and cerebrovascular disease. POC coagulation testing plays a crucial role in CVD treatment by providing real-time information on coagulation status, enabling timely interventions and reducing the risk of bleeding complications, particularly after cardiac surgery. For example, in May 2023, the Centers for Disease Control and Prevention reported that heart disease claimed about 695,000 lives in the United States in 2021, accounting for 1 in 5 deaths. Coronary heart disease, the most common type, caused 375,476 deaths in 2021. This increasing prevalence of cardiovascular diseases is a key driver behind the growth of the POC coagulation testing market.

Major companies in the point-of-care (POC) coagulation testing market are concentrating on strategic collaborations to enhance their competitive position. These collaborations involve formal agreements between two or more parties to work towards specific, mutually beneficial goals. For example, in October 2021, Trivitron Healthcare partnered with Diagon Ltd. and Vanguard Diagnostics to introduce Coagulation Analyzer products. These analyzers offer precise and efficient coagulation testing, with the collaboration aimed at enhancing patient diagnosis and management. The range of analyzers is designed to cater to various healthcare settings, making coagulation testing more accessible.

In December 2023, Roche, a Switzerland-based pharmaceutical company, acquired LumiraDx Ltd. for $350 million. This acquisition enhances Roche's diagnostics portfolio, enabling more patient-centric healthcare through point-of-care solutions that cover the entire patient journey. LumiraDx Ltd., based in the UK, specializes in point-of-care coagulation testing.

Major companies operating in the point-of-care (POC) coagulation testing market report are AT&T Corporation, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Medtronic Plc, Koninklijke Philips N.V., Sysmex Corporation, IDEXX Laboratories Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Teleflex Incorporated, Werfen SA, Nihon Kohden Corporation, Horiba Ltd., Hycel, Nova Biomedical Corporation, Haemonetics Corporation, Maccura Biotechnology Co. Ltd., Helena Laboratories Corporation, Abaxis Inc., ARKRAY Inc., Radiometer Medical ApS, HemoSonics LLC, iLine Microsystems SL, Corgenix Medical Corporation, Quotient Limited, Micropoint Bioscience Inc., Beijing Succeeder Technology Inc., EKF Diagnostics Holdings plc

North America was the largest region in the point-of-care (POC) coagulation testing market in 2024. The regions covered in the point-of-care (poc) coagulation testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the point-of-care (poc) coagulation testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The point-of-care (POC) coagulation testing market consists of revenues earned by entities by providing coagulation testing services, on-site hemostasis testing, point-of-care diagnostic services, and rapid coagulation analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care (POC) coagulation testing market also includes sales of coagulation analyzers, test strips, prothrombin time (PT) monitors, D-dimer testing devices, and point-of-care coagulation testing kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point-of-Care (POC) Coagulation Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on point-of-care (poc) coagulation testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for point-of-care (poc) coagulation testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The point-of-care (poc) coagulation testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Point-of-Care (POC) Coagulation Testing Market Characteristics

3. Point-of-Care (POC) Coagulation Testing Market Trends And Strategies

4. Point-of-Care (POC) Coagulation Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Point-of-Care (POC) Coagulation Testing Growth Analysis And Strategic Analysis Framework

6. Point-of-Care (POC) Coagulation Testing Market Segmentation

7. Point-of-Care (POC) Coagulation Testing Market Regional And Country Analysis

8. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market

9. China Point-of-Care (POC) Coagulation Testing Market

10. India Point-of-Care (POC) Coagulation Testing Market

11. Japan Point-of-Care (POC) Coagulation Testing Market

12. Australia Point-of-Care (POC) Coagulation Testing Market

13. Indonesia Point-of-Care (POC) Coagulation Testing Market

14. South Korea Point-of-Care (POC) Coagulation Testing Market

15. Western Europe Point-of-Care (POC) Coagulation Testing Market

16. UK Point-of-Care (POC) Coagulation Testing Market

17. Germany Point-of-Care (POC) Coagulation Testing Market

18. France Point-of-Care (POC) Coagulation Testing Market

19. Italy Point-of-Care (POC) Coagulation Testing Market

20. Spain Point-of-Care (POC) Coagulation Testing Market

21. Eastern Europe Point-of-Care (POC) Coagulation Testing Market

22. Russia Point-of-Care (POC) Coagulation Testing Market

23. North America Point-of-Care (POC) Coagulation Testing Market

24. USA Point-of-Care (POC) Coagulation Testing Market

25. Canada Point-of-Care (POC) Coagulation Testing Market

26. South America Point-of-Care (POC) Coagulation Testing Market

27. Brazil Point-of-Care (POC) Coagulation Testing Market

28. Middle East Point-of-Care (POC) Coagulation Testing Market

29. Africa Point-of-Care (POC) Coagulation Testing Market

30. Point-of-Care (POC) Coagulation Testing Market Competitive Landscape And Company Profiles

31. Point-of-Care (POC) Coagulation Testing Market Other Major And Innovative Companies

32. Global Point-of-Care (POC) Coagulation Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Point-of-Care (POC) Coagulation Testing Market

34. Recent Developments In The Point-of-Care (POC) Coagulation Testing Market

35. Point-of-Care (POC) Coagulation Testing Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â